Are GLP-1 Analogues a New Solution for the Treatment of NAFLD?
ABSTRACT Introduction and purpose: There is currently a pandemic of overweight and obesity, which is closely associated with non-alcoholic fatty liver disease (NAFLD). It is the most common cause of chronic liver disease [1]. The global prevalence of this condition reaches 25% of the populati...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2024-12-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/56304 |